Skip to main content
Caplight Logo









CellAxia Inc.

CellAxia Inc.

Private
TokyoHealthcare & Life Scienceshttps://www.cellaxia.co.jp/

Last Round

VC Round

May 31, 2024

Total Funding Raised

$11.3M

Company Overview

CellAxia Inc. is a biopharmaceutical company developing next-generation therapeutics for intractable and rare diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

cell therapyregenerative medicinedrug discoveryrare diseasesorphan drugsintractable diseasesbiotechnologysomatic stem cellsbioventuredrug licensingpharmaceutical R&Dregulatory lymphocytesregen med

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CellAxia Inc. Comparables

Compare CellAxia Inc. with similar companies based on industry and business-model similarity.

CellAxia Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Healios K.K.
76%
Rege Nephro Co., Ltd.
75%
RegCell, Inc.
74%

CellAxia Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 31, 2024
Series CAug 19, 2022
Series BSep 10, 2020
SeedJan 16, 2018

CellAxia Inc. Investors

Notable investors and investment history

CellAxia Inc. investors
InvestorRounds
Mizuho CapitalSeries C, Series B
Oita Venture Capital Co., Ltd.Series C
株式会社FFGベンチャービジネスパートナーズSeries B
Mitsubishi UFJ CapitalSeries C, Series B, Seed
SBI Okasan Alternative Investment Co., Ltd.Series C, Series B
Miyako CapitalSeries C, Series B
AJ Capital 株式会社Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 31, 2024

    Funding round led by Ricoh Biomedical Startup Fund.

  • Aug 19, 2022

    $4.7M round with participation from Mitsubishi UFJ Capital.

CellAxia Inc. Filings

Explore SEC and related filing metadata, where available.

CellAxia Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CellAxia Inc.'s valuation, stock price, and market status.

Is CellAxia Inc. a public or private company?

CellAxia Inc. is a private company.

What is the current stock price of CellAxia Inc.?

CellAxia Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is CellAxia Inc. worth (valuation)?

Valuation information for CellAxia Inc. is not publicly available.

Can I buy CellAxia Inc. stock?

CellAxia Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CellAxia Inc.'s last funding round?

Funding round information for CellAxia Inc. is not publicly available.

Who are the main investors in CellAxia Inc.?

Investor information for CellAxia Inc. is not publicly disclosed.

Will CellAxia Inc. IPO soon?

No public IPO plans have been announced for CellAxia Inc..

How can I track CellAxia Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CellAxia Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTokyo
Year Founded2017
Last FundingMay 31, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?